The combination of Bacillus Calmette Guerin (BCG) with anti-COX-2 selective molecules and/or COX-2 preferential FANS for the treatment of pathologies related to the loss of macrophages functions and deficiencies of cell-mediated immunity.


Sign in to the Lens

Release 5.10.0: Improved patent search performance, saved query alerts, increased user privacy and more!

Improved Search Performance

Upgraded patent search index servers to improve search performance.

Saved Query Alerts.

Improvements to in saved query alerts emails and better formatting of links.

Increased User Privacy.

Removed Google Maps dependency in a Patents Family page.